Europe — EMA

Paclitaxel Accord Healthcare Italia

Paclitaxel, the active ingredient in Paclitaxel Accord Healthcare Italia, is a taxane presented as a sterile powder for intravenous infusion use.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Accord Healthcare Italia, is a taxane presented as a sterile powder for intravenous infusion use. It treats various solid tumours and is administered to adult oncology patients. GNH USA supplies Paclitaxel Accord Healthcare Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Paclitaxel Accord Healthcare Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Paclitaxel used for?

Paclitaxel is a chemotherapeutic agent used in the treatment of several solid tumours:

- Breast cancer: improves the overall response rate and survival when combined with anthracycline‑based regimens. - Non‑small cell lung cancer: used as a first‑line treatment in combination with carboplatin. - Ovarian cancer: administered as maintenance therapy to prolong progression‑free survival. - Cervical cancer and endometrial cities : … … … … … … … … … … … … - … .... … .... …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →